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Abstract
There is a link between the pregnancy and its long-term influence on health and susceptibil-
ity to future chronic disease both in mother and offspring. The objective was to determine
whether individual counseling on physical activity and diet and weight gain at five antenatal
visits can prevent type 2 diabetes mellitus (T2DM) and overweight or improve glycemic
parameters, among all at-risk-mothers and their children. Another objective was to evaluate
whether gestational lifestyle intervention was cost-effective as measured with mother’s sick-
ness absence and quality-adjusted life years (QALY). This study was a seven-year follow-
up study for women, who were enrolled to the antenatal cluster-randomized controlled trial
(RCT). Analysis of the outcome included all women whose outcome was available, in addi-
tion with subgroup analysis including women adherent to all lifestyle aims. A total of 173
women with their children participated to the study, representing 43% (173/399) of the
women who finished the original RCT. Main outcome measures were: T2DM based on med-
ication use or fasting blood glucose or oral glucose tolerance test (OGTT), body mass index
(BMI), glycosylated hemoglobin (HbA1c). None of the women were diagnosed to have
T2DM. HbA1c or fasting blood glucose differences were not found among mothers or chil-
dren. Differences in BMI were non-significant among mothers (Intervention 27.3, Usual care
28.1 kg/m2, p = 0.33) and children (I 21.3 vs U 22.5 kg/m2, p = 0.07). Children’s BMI was
significantly lower among adherent group (I 20.5 vs U 22.5, p = 0.04). The mean total cost
per person was 30.6% lower in the intervention group than in the usual care group (I €2,944
vs. U €4,243; p = 0.74). Intervention was cost-effective in terms of sickness absence but not
in QALY gained i.e. if society is willing to pay additional €100 per one avoided sickness
absence day; there is a 90% probability of the intervention arm to be cost-effective. Long-
term effectiveness of antenatal lifestyle counseling was not shown, in spite of possible effect
on children’s BMI. Cost-effectiveness of the intervention in terms of sickness absence may
have larger societal impact.
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Introduction
There is a link between the pregnancy and its long-term influence on health and susceptibility
to future chronic disease both in mother and offspring [1]. Inactivity and unhealthy eating
habits during pregnancy increase risk for prenatal excess weight gain and increase risk for type
2 diabetes mellitus (T2DM) and cardiovascular diseases later in life [2, 3]. Additionally, mater-
nal obesity may predispose children for impaired glucose tolerance, [4] and increase also risk
for childhood obesity [5–7].
The importance of maternal lifestyle counseling is obvious, because globally 37.3% of adult
women are overweight or obese [8] and 26.8% are inactive (i.e. not meet the physical activity
recommendation) [9]. In Finland the situation is even worse, because 48.6% of adult women
are at least overweight (body mass index 25) and 28.1% are inactive [8, 9]. Pregnancy and
postpartum period may predispose women to healthy lifestyle and prevent future chronic dis-
eases. Consequently both individualized dietary counseling and support to at least moderate
intensity physical activity or combination of them has shown to be restrain gestational weight
gain on healthy pregnant women [10, 11] but the effect of diet and exercise interventions on
gestational diabetes mellitus (GDM) incidence is limited [12, 13]. We have previously reported
favorable changes in diet composition and proportion of large-for-gestational-age newborns
in a cluster-randomized trial in order to prevent GDM [14–17]. However, long-term effective-
ness of lifestyle counseling interventions among women with risk of GDM or their children
have not yet been published in our or any other trial.
Short-term cost-effectiveness of our own lifestyle counseling intervention among GDM
risk group was not favorable for birthweight, quality of life (15D) or perceived health [18]. Par-
allel negative cost-effectiveness findings to our trial were reported in Oostdam et al. [19] study,
where maternal fasting blood glucose, insulin sensitivity or quality-adjusted life year (QALY)
were used as outcome indicators.
Objective for this study was to determine whether lifestyle counseling during pregnancy
can prevent T2DM, glucose intolerance or overweight among all at-risk-mothers and their
children and for women adherent to all lifestyle aims during gestation. Hypothesis was that
T2DM can be prevented in the long term implementing individual physical activity and die-
tary counseling, because overweight, glucose-intolerance and type 1 or 2 diabetes in first- or
second-degree relatives are strong risk factors for T2DM later in life. Another objective was to
evaluate whether gestational lifestyle intervention was cost-effective as measured with mother’s
sickness absence and quality-adjusted life years.
Materials and Methods
Study design and participants
The study was a 7-year follow-up study (mean 7.2, median 7.2, range 5.6–8.3) of the cluster
randomized lifestyle counseling trial among women with risk of GDM (n = 399) (trial registra-
tion ISRCTN33885819; see http://www.controlled-trials.com/) [16, 20]. For this 7-year-follow-
up study were invited all participants in the original intervention who were along at the end of
the trial. Women participating to the original trial from the beginning to the end of pregnancy
(N = 399) and were willing to participate to the follow-up study (N = 173), were included to
the analysis of this article. Response rate to the follow-up study was therefore 43.4% (173/399).
The research was conducted in accordance with prevailing ethics principles. Written informed
consent was obtained from the mothers and from the guardians on behalf of the children
enrolled in study. The informed consent and all questionnaires were recorded. This follow-
up study and written informed consent procedure were approved by the medical ethics
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committees of the Pirkanmaa hospital district (R14039). The follow-up study was performed
between May 2014 and January 2016.
Original RCT trial. Public health nurses recruited women willing to participate during
their first visit to the antenatal clinic. Women who met at least one of the GDM risk factors
were included: BMI 25 kg/m2, GDM or a macrosomic newborn ( 4500 g) in any earlier
pregnancy, any sign of glucose-intolerance, type 1 or 2 diabetes in first- or second-degree
relatives, or age  40 years, were recruited to the trial. The exclusion criteria were type 1 or
2 diabetes before pregnancy, inadequate proficiency in the Finnish language for the study,
age < 18 years, twin pregnancy, physical limitations preventing physical activity, and a
pathological value in baseline oral glucose-tolerance test (OGTT) at 8–12 or 26–28 weeks’
gestation.
The intervention involved five out of the 11–15 recommended antenatal care visits, which
were divided evenly during gestation from 8–12 until 37 weeks. With the intervention group,
the public health nurses focused on combined dietary and physical activity counseling, which
were based on national physical activity and dietary recommendations, personalised goals, and
regular follow-up on targets aiming to restrain gestational weight gain [20]. Women who were
slightly physically active and had an uncomplicated pregnancy were encouraged to engage
according to physical activity recommendation at least 150 minutes of moderate or 75 minutes
vigorous leisure-time activity at least three days a week with the suggested approach being
sessions of 10 minutes duration or more [21]. The women at the control maternity clinics
received only routine care and no counseling beyond the usual care. However, in Finland rou-
tine maternity care includes some dietary and physical activity counseling [16, 20].
7-year follow-up. All participants of the original RCT were invited to 7-year follow-up
visit, which consisted of physical measurements (OGTT and blood samples), anthropomet-
ric measurements (weight, height and waist circumference) and blood pressure. In addition,
children who were born during the intervention were invited to participate with their moth-
ers. Blood sampling concerned both mother and the child in order to analyse fasting blood
sugar and glycosylated hemoglobin HbA1c. Women filled also a questionnaire with ques-
tions on lifestyle habits, use of health care services, medication, sickness absence, quality of
life and workability. The follow-up questionnaire included the same questions as the original
RCT, with addition of more details concerning mother’s mental health, psychological well-
being, workability, physical activity, sedentary behaviour, children’s diet, physical activity
and chronic diseases. Women were contacted up to 3 times using all possible ways (by
phone, e-mail and social media) in order to increase participation to the follow-up measure-
ments. Since we did not have information on outcome variable from all women, intention
to treat- analysis was not possible to be performed. Analysis of the outcome included all
women whose outcome was available, in addition with subgroup analysis including women
adherent to all lifestyle aims.
Outcome measurements
The long-term effectiveness of the lifestyle intervention was evaluated in term of mothers’
prevalence for T2DM. Secondary outcomes were mother’s body mass index (BMI) and quality
of life measured using 15D but also children’s BMI, glycosylated hemoglobin (HbA1c) and
fasting blood glucose. T2DMwas determined based on at least one of the following criteria: 1)
data on use of medication for T2DM, 2) self-reported information on diagnosed T2DM, 3)
fasting blood glucose (> 7.0 mmol/l) or 4) Oral glucose tolerance test (OGTT) (> 11.0 mmol/l
two-hour) or 5) HbA1c-measurement ( 48 mmol/mol; 6,5%) [22]. Children’s BMI were
calculated using BMI for age calculator for children aged 2–20 years [23].
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Cost-effectiveness of the intervention seven years after the original RCT was evaluated in
terms of sickness absence and QALY gained. Sickness absence was calculated combining all
days in sick leave in spite of the reason during last year (mother’s own or children’s sickness).
The QALY data were calculated from the standardized 15D questionnaire, which is a validated
instrument for measuring health-related quality of life (HRQoL) [24, 25]. The 15D involves 15
separate dimensions: mobility, vision, hearing, breathing, sleeping, eating, speech, excretion,
usual activities, mental function, discomfort and symptoms, depression, distress, vitality, and
sexual activity. In generation of the overall HRQoL score, the 15 dimensions are covered by a
single index number, from 0 (representing the death) to 1 (denoting the best health state) [24].
To calculate QALY gained the difference in index score between 7-year follow-up and the
baseline was taken into account and the index was multiplied by the expected lifetime calcu-
lated for each woman separately.
Physical activity was assessed by accelerometer (Hookie AM20, Traxmeet Ltd, Espoo, Fin-
land) signal from three orthogonal directions in raw mode with 100 Hz sampling frequency
and ±16 g measurement range. The data was analysed in 6’s epoch length. The accelerometer
was attached to an elastic belt on the right side of the waist. The collected raw acceleration data
was transformed into actual g-units [26, 27]. Women carried accelerometers for one week (7
consecutive days) in order to achieve objective measurement of usual physical activity. To
analyses were included only cases who kept the device at least four days per and at least 10
hours a day. Sedentary behaviour (including lying down and sitting) and standing still were
defined as activity corresponding less than 1.5 MET, light physical activity 1.5–2.9 MET and
moderate-to-vigorous physical activity 3.0 MET and over.
Adherent women. Women were defined to be adherent to the recommendations during
intervention, if they fulfilled at least three of the five dietary aims and/or their self-reported
physical activity exceeded 800 METminutes/weeks at 36–37 weeks’ gestation and their total
weight gain did not exceed their BMI-specific limits which provide limits for weight gain dur-
ing pregnancy. This definition was reported in the original results of the RCT [16].
Costs
The economic evaluation included the health-care costs to the municipality, costs raised by the
patient, medication and productivity costs from the societal perspective. The information on
the use of all health care services (visits to a doctor, a nurse, public health nurse, physiothera-
pist and in-patient days) during the last 12 months, a number of sickness absence days and
medication were obtained by questionnaire. The medication cost included both the patient-
and the society-borne amount; in 2015 medication costs were 35% contributing by the society,
with patient covered the rest of the amount [28,29]. The health care costs were based on aver-
age national costs for health care [30]. The unit costs of visits to physicians and to nurses
included salary costs and administrative costs but not laboratory expenses. In addition, the
unit cost of inpatient hospital days included the daily inpatient-care charge [30].
All costs were calculated for the 12-month period retrospectively. The unit costs, productiv-
ity costs, and medication costs were entered at 2015 price level, in euros [31]. Lost productivity
was evaluated by means of self-reported information on absence from part- or full-time work
via a questionnaire 12 months retrospectively. At questionnaire was separated absence from
work according to reason (mother’s own sickness or children’s sickness). However, at cost-
effectiveness analysis all sickness days were added up because in spite of the reason they all
increase productivity costs. The salary costs were calculated from women’s average national
monthly salary scales in 2014 [32] multiplied by 1.3 to encompass related expenses and entered
at 2015 price level. The cost calculation assumed 220 workdays a year. The travel expenses and
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time costs related to the use of health services were not taking into account because this infor-
mation was not available.
Statistical analysis
Baseline characteristics, effects and costs were reported as means and standard deviation (SD)
or as frequencies and percentages. The difference between the groups was tested with the T-
test and Chi-squared test. Children’s fasting blood sugar was only exception, which was tested
with Mann-Whitney U-test, because data was not normally distributed. P-values for outcomes
were calculated using linear regression and the baseline (gestational week 8–12) was used to
standardize the effect.
To evaluate cost-effectiveness, the differences between groups were analysed via a non-
parametric bootstrap approach. Cost effectiveness was expressed in terms of incremental cost-
effectiveness ratios (ICERs), which indicate the amount of money that is required to decrease
days of sickness absence and increase QALYs gained. Health-related quality of life was judged
on the basis of the standardised 15D questionnaire. A bootstrap technique with 5,000 replica-
tions [33] and cost-effectiveness acceptability curves were used to assess 95% confidence inter-
vals for purposes of analysing the uncertainty around the point estimate of the ICER. The
formula for calculation of ICER is
ICER ¼ ðCostIntervention   CostControlÞ= ðEffectIntervention   EffectControlÞ
The confidence intervals (CIs) were calculated by means of a bias-corrected and accelerated
(BCa) method proposed by Efron [34]. The BCa interval is given in terms of percentiles of
the bootstrap distribution of differences in means, but the percentiles used are chosen after
correction for skewness or ‘acceleration’ aˆ and bias [35]. Missing values (costs) were imputed
by using mean values of costs. The results were considered to be statistically significant if
p< 0.05. Analyses were performed with SPSS (version 22) and Stata (version 12.1) statistics
software.
Sensitivity analysis. To evaluate the robustness of the findings, we performed sensitivity
analysis in two separate ways. Firstly, we standardized the productivity costs between groups,
because sickness absence was the highest separate cost. The second sensitivity analysis was a
complete case analysis. This entailed including only those participants whose data were avail-
able in full, without imputation with respect to direct and productivity cost and the 15D data.
Results
A total of 173 (43.4%) participants of 399 original RCT were willing to participate the follow-
up study. Included participants were almost equally from the original intervention (n = 85)
and usual care group (n = 88) (Fig 1). The remainder 139 (34.8%) were not willing to partici-
pate and 87 (21.8%) were out of reach. Participant’s background information (age, education,
smoking, number of children and working situation) did not differ between the intervention
and usual care groups (Table 1).
None of the women who were involved in the intervention or usual care group had T2DM
or prediabetes or medication for T2DM or abnormal result in fasting blood glucose or 2-hour
measurement in OGTT (Table 2). Additionally, glycosylated hemoglobin (HbA1c) was similar
between the groups and all values were normal (Table 2). BMI was non-significantly lower in
the intervention group as compared to the usual care group (27.3 vs. 28.1, p = 0.33). Waist cir-
cumference was almost the same in both groups (89.9 cm vs. 90.9 cm, p = 0.63).
Objectively measured moderate-to-vigorous physical activity time at seven-year follow-up
was on average 38 minutes per day in both groups (Table 2). Objectively measured total
Effectiveness and Cost-Effectiveness of GDM Prevention: A Seven-Year Follow-Up
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Fig 1. Flow diagram of the cluster-randomized trial from enrollment till 7 year follow-up.
doi:10.1371/journal.pone.0167759.g001
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physical activity (i.e., light, moderate and vigorous physical activity), did not differ between
the groups either (4.41 hours vs. 4.54 hours, p = 0.30; Table 2). Respectively quality of life score
(on 0–1 scale) at follow-up did not differ between the groups (0.94 vs. 0.93, p = 0.30; Table 2).
Like in adults, children’s BMI at follow-up was on average lower among those whose mother
attended at intensified physical activity and dietary counseling intervention (21.3 vs. 22.5,
p = 0.07; Table 2) in which also age was taken into account. Glucose tolerance measurements
(fasting blood glucose and glycosylated hemoglobin) of children were similar in both groups.
Costs
The mean total cost per person was 30.6% lower in the intervention group than in the usual
care group (€2,944 vs. €4,243; p = 0.74; Table 3). Absence from work was the highest separate
cost in both groups but did not differ significantly between the groups either (means €1,992
vs. €3,070 and medians €1,351 vs. €1,158; p = 0.93).When absence from work was analyzed
separately according to reason there was no considerable difference between the groups in the
absence from work because of children (4.0 days vs. 5.0 days, p = 0.83, not shown in table).
Meanwhile, women who were in the intervention group had on average 6.3 absence days dur-
ing the last year and usual care group 11.3 days respectively (p = 0.55) because of women’s
own sickness (not shown in table).
Cost-effectiveness
The incremental cost-effectiveness ratio (ICER) for absence from work was €-233 (Table 4).
As the cost-effectiveness plane indicates (Fig 2), overall 90.6% of bootstrap pairs locate in the
south-east quadrant indicating that the intervention after seven years of implementation was
still cost-effective in terms of sickness absence. In other words, if society is willing to pay addi-
tional €100 per one avoided sickness absence day; there is a 90% probability of the interven-
tion arm to be cost-effective (Fig 2). The ICER for QALY was -€5,386 (Table 4) with bootstrap
68.2% located in south-east quadrant (Fig 3). Intervention was not cost-effective for QALY
gained because study indicated only 70% of probability of cost-effectiveness if society is willing
to pay €33,000 per one-point improvement in QALY gained (Fig 3 and Table 4).
Table 1. Characteristics (mean ± SD or frequency and percentage).
Intervention group n = 85 Usual care group n = 88 p Missing (Intervention/Control)
Age 37.7 (4.5) 38.1 (4.9) 0.66 -
Education level 0.23 2/0
Low 25 (30.1%) 25 (28.4%)
Medium 28 (33.7%) 40 (45.5%)
High 30 (36.1%) 23 (26.1%)
Smoking 0.88 5/3
No 73 (91.3%) 77 (90.6%)
Occasionally / daily 7 (8.7%) 8 (9.4%)
Number of children 0.42 6/4
1 8 (10.1%) 12 (14.3%)
2 71 (89.9%) 72 (85.7%)
Work 0.68 5/3
Full- or part-time work 57 (71.3%) 63 (74.1%)
Other (e.g. unemployed) 23 (28.7%) 22 (25.9%)
Gestational diabetes during pregnancy 5 (6.3%) 4 (4.8%) 1
doi:10.1371/journal.pone.0167759.t001
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Adherent group in original RCT. The adherent women (n = 24) had on average lower
HbA1c value (33.7 vs. 34.8, p = 0.09; not shown in table) and higher quality of life (0.95 vs.
0.93, p = 0.09) compared to usual care group after seven years of intervention. Respectively
children’s age perceived BMI was lower in adherent group (20.5 vs. 22.5, p = 0.04). There were
no differences between adherent and usual care group in other variables.
Sensitivity analysis
The first sensitivity analysis applied the assumption that the productivity costs were in the
intervention group as high as in the usual care group and the second was a complete case anal-
ysis. The results of complete case analysis were quite similar to those in the basic analysis
(Table 4).
Discussion
Our follow-up study was not able to show effectiveness of gestational lifestyle counseling inter-
vention on prevention of glucose intolerance or T2DM. In subgroup analysis children of the
women adherent to the lifestyle aims had lower BMI as compared to children from usual care
group mothers. Intervention was not cost-effective for QALY gained, but was cost-effective for
sickness absence from work during last year.
Table 3. Annual mean health care costs (mean and SD) and productivity costs.
Intervention group
(n = 80)
Control group (n = 85)
Unit cost
(EUR)
Number of
units
Mean cost
(EUR)
Number of
units
Mean cost
(EUR)
p-value
Direct costs
Occupational health care
doctor
78/ visit 1.5 (2.2) 113.5 1.7 (4.5) 131.4 0.76
Primary care doctor 117/ visit 0.9 (1.5) 105.6 1.3 (1.5) 148.7 0.013
Special health care doctor 310/ visit 0.6 (1.0) 185.8 0.9 (2.2) 284.6 0.86
Registered nurse in primary
care
51/ visit 0.4 (1.5) 21.1 0.4 (1.2) 18.6 0.21
Public health nurse in
occupational health
42/ visit 0.5 (0.9) 19.0 0.5 (0.9) 19.0 0.87
Public health nurse in
maternity clinic
58/ visit 0.9 (2.9) 52.6 0.5 (1.7) 26.9 0.56
Public health nurse in child
health clinic
53/ visit 0.6 (1.6) 32.0 0.4 (0.9) 21.0 0.95
Public health nurse in
family planning clinic
51/ visit 0.03 (0.16) 1.3 0.12 (0.62) 6.1 0.065
Physiotherapist 60/ visit 0.8 (2.5) 45.1 0.5 (1.7) 31.0 0.66
Medication 268.2 238.6 0.17
Inpatient days in primary
care
250/ day 0.06 (0.40) 15.6 - 0.3 0.73
Inpatient days in special
health care
820/ day 0.11 (0.50) 92.3 0.31 (1.18) 246.8 0.12
Total direct costs 952 1,173 0.33
Productivity costs
Absence from work
(€3,534/month)
193/day 10.3 (18.3) 1,992 16.1 (32.7) 3,070 0.93
Total costs 2,944 4,243 0.74
doi:10.1371/journal.pone.0167759.t003
Effectiveness and Cost-Effectiveness of GDM Prevention: A Seven-Year Follow-Up
PLOS ONE | DOI:10.1371/journal.pone.0167759 December 9, 2016 9 / 16
Lack of effectiveness may be due to several reasons. First of all, it may be consequence of
low intensity and similarities of the original counseling program as compared to the usual care
group.
We have reported in our results from main trial [16] that usual care group participants
received dietary counseling without specific aims or advices related to physical activity or ges-
tational weight gain. Since diet is an important factor in prevention and treatment of diabetes,
the differences in the groups may have been smaller than previously admitted. Overall effec-
tiveness of the health behavior trials is rather low, based on previous reviews [12, 13, 36, 37].
Second reason for lack of effectiveness is found from low response rate of the study. More
than one third of the women were reached but they were unwilling to participate oral glucose
tolerance test or other measurements. Low response rate leads to low power, which cannot be
denied in our results. It may also be possible that non-participating women had more adverse
glucose intolerance profile and prevalent cases of T2DM, whereas the participating women
were a selected healthy sample. Thus, healthy selection bias cannot be rejected when discussing
the results of the study. On the other hand, proportion of drop-out women was equal in both
groups in the follow-up study, thus increasing the reliability of the comparisons. This result
also means that prevention of overt diabetes was successful in both groups, which can be con-
sidered as beneficial for all women participating to the original trial.
Thirdly, our results concerning the adherent group children’s BMI suggest that even small
gestational changes in lifestyle may produce meaningful consequences to second generation.
Table 4. Mean costs and effect differences (95% CI) between the intervention and usual care group
and the sensitivity analysis, including incremental cost-effectiveness ratios and cost-effectiveness
plane distributions.
Sample size Costs (EUR) Effects ICER Distribution on CE
plane (%)*
Intervention
group
Control
group
Δ of
intervention
—usual care
(95% CI)
Δ of
intervention
—usual care
(95% CI)
NE SE SW NW
Main
analysis
Absence from
work
80 83 -1,356 (-3,862
to 248)
5.82 (-1.26 to
15.7)
-233 2.1 90.6 1.7 5.6
QALYs 80 85 -1,300 (-3,600
to 224)
0.24 (-0.61 to
0.96)
-5,386 4.9 68.2 24.4 2.5
Equal
productivity
costs
Absence from
work
80 83 -233 (-978 to
306)
5.82 (-1.26 to
15.7)
-40 21.6 71.1 4.0 3.3
QALYs 80 85 -221 (-931 to
286)
0.24 (-0.61 to
0.96)
-917 17.3 55.8 19.9 7.0
Complete
case
analysis
Absence from
work
80 82 -1,394 (-4,002
to 97)
6.00 (-0.52 to
16.2)
-232 1.6 91.8 1.6 5.0
QALYs 80 82 -1,394 (-4,002
to 97)
0.20 (-0.65 to
0.91)
-6,949 4.2 65.8 27.6 2.4
* 95% CI: 95% confidence interval (‘bias-corrected and accelerated’ method), NE: north-east, SE: south-
east, SW: south-west, NW: north-west.
doi:10.1371/journal.pone.0167759.t004
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The finding of lower BMI among children may induce considerable cost savings later in life,
because overweight increases the risk for T2DM and cardiovascular diseases later in life [3].
Although intervention was not cost-effective for QALY gained, cost-effectiveness for
absence from work was a significant finding because the additional positive effect was gained
at a very low price. Based at this study there is 90% probability that cost of €100 might
shorten absence from work one day, which is half of workday’s cost to the society defined at
this study (€193). From economical perspective, investment for more detailed and 2.5 hours
Fig 2. Cost-effectiveness plane and acceptability curve for absence from work.
doi:10.1371/journal.pone.0167759.g002
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Fig 3. Cost-effectiveness plane and acceptability curve for QALY gained.
doi:10.1371/journal.pone.0167759.g003
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longer lifestyle counseling [16] may save health care costs and decrease amount of sickness
absence among women with risk of GDM. Procedures which increase physical activity and
healthy nutrition and prevent excessive weight gain during pregnancy may save further
health care costs because of mother’s and children’s lower BMI and decrease costs due to
sickness absence.
On average 70% of total costs at this study were due to absence from work because of moth-
ers own sickness or children’s sickness and 30% respectively were arisen because of use of
health care services and medication. Since absence from work was the highest individual cost
of all analyzed variables women should invest in their own work capacity, which may also
improve women’s quality of life. However, reasons for lower sickness absence among interven-
tion group remains unclear. According to Rasmussen et al. [38] high self-reported physical
capacity was associated with lower long-term sickness absence among female health care
workers. However, information on our study participant’s current physical capacity was not
available.
One weakness of the study was that the follow-up study included only costs of the latest
year; cost information was not available for longer time. However, we have no reason to
believe that the latest year would have not been an average one. Cost-effectiveness of interven-
tion was reported earlier [18] but cost data was not consistent with the latest year since the
pregnancy.
Our study is the first follow-up study of a gestational lifestyle intervention, which included
data both from mother and children. In addition, the advantage of the study was that sickness
absences for less than ten days were included. Usually that information remains mainly at
occupational health care and is not public information. Nearly half (48.6%) of the adult
women are at least overweight (BMI 25 kg/m2) according to the latest reports [8]. Therefore,
our findings may be generalized to the similar risk groups in other countries. There is a need
for more long-term effectiveness and cost-effectiveness studies to examine findings related to
GDM risk group.
Conclusions
Pregnancy has both short- and long-term influences on health and susceptibility to future
chronic disease both in mothers and their offspring. According to our findings, effectiveness
of the lifestyle intervention was low, but none of the women who were involved in the follow-
up study were diagnosed as having T2DM. Seven years after the intervention children’s BMI
was lower in the intervention group of adherent mothers compared to usual care group. Long-
term cost-effectiveness was found in absence from work but not in QALY gained. Procedures
which increase physical activity and healthy nutrition and prevent excessive weight gain dur-
ing pregnancy may save further health care costs because of children’s lower BMI and decrease
costs due to sickness absence. There is a need for more long-term effectiveness and cost-effec-
tiveness studies to examine whether findings with GDM risk group were equal with other post-
natal women and their children.
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